Boncler, M A <br/><br/>
Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin.  [electronic resource] 

 -  Thrombosis research  Nov 2001 
 - 215-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/s0049-3848(01)00357-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aptamers, Nucleotide<br/>Blood Coagulation Tests<br/>Blood Platelets--drug effects<br/>Dose-Response Relationship, Drug<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Fibrin--biosynthesis<br/>Flow Cytometry<br/>Humans<br/>Male<br/>Middle Aged<br/>Oligonucleotides--pharmacology<br/>Platelet Aggregation--drug effects<br/>Receptor, PAR-1<br/>Receptors, Thrombin--metabolism<br/>Thrombin--antagonists & inhibitors